ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
SZSE:301234
Balance Sheet
Balance Sheet Decomposition
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
Balance Sheet
ANHUI HONGYU WUZHOU Medical Manufacturer Co Ltd
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
67
|
49
|
41
|
102
|
268
|
153
|
|
| Cash |
63
|
49
|
41
|
102
|
268
|
153
|
|
| Cash Equivalents |
4
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
6
|
0
|
261
|
75
|
221
|
|
| Total Receivables |
94
|
84
|
100
|
110
|
110
|
124
|
|
| Accounts Receivables |
80
|
75
|
90
|
93
|
93
|
108
|
|
| Other Receivables |
14
|
9
|
10
|
17
|
17
|
16
|
|
| Inventory |
35
|
46
|
52
|
52
|
47
|
45
|
|
| Other Current Assets |
2
|
6
|
13
|
6
|
7
|
4
|
|
| Total Current Assets |
198
|
190
|
206
|
531
|
508
|
548
|
|
| PP&E Net |
111
|
128
|
166
|
301
|
332
|
317
|
|
| PP&E Gross |
111
|
128
|
166
|
301
|
332
|
317
|
|
| Accumulated Depreciation |
51
|
64
|
82
|
100
|
123
|
157
|
|
| Intangible Assets |
7
|
7
|
8
|
8
|
7
|
7
|
|
| Other Long-Term Assets |
3
|
2
|
3
|
5
|
1
|
1
|
|
| Total Assets |
320
N/A
|
327
+2%
|
383
+17%
|
845
+120%
|
848
+0%
|
873
+3%
|
|
| Liabilities | |||||||
| Accounts Payable |
83
|
73
|
65
|
79
|
60
|
62
|
|
| Accrued Liabilities |
9
|
10
|
11
|
14
|
15
|
15
|
|
| Short-Term Debt |
34
|
32
|
13
|
0
|
1
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
47
|
7
|
22
|
16
|
12
|
14
|
|
| Total Current Liabilities |
173
|
123
|
111
|
109
|
89
|
93
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
1
|
0
|
0
|
2
|
3
|
|
| Other Liabilities |
9
|
8
|
9
|
12
|
8
|
13
|
|
| Total Liabilities |
182
N/A
|
133
-27%
|
120
-9%
|
121
+1%
|
98
-19%
|
110
+12%
|
|
| Equity | |||||||
| Common Stock |
51
|
51
|
51
|
68
|
68
|
68
|
|
| Retained Earnings |
64
|
121
|
189
|
260
|
286
|
299
|
|
| Additional Paid In Capital |
23
|
23
|
23
|
395
|
395
|
395
|
|
| Total Equity |
138
N/A
|
194
+41%
|
263
+35%
|
723
+175%
|
750
+4%
|
762
+2%
|
|
| Total Liabilities & Equity |
320
N/A
|
327
+2%
|
383
+17%
|
845
+120%
|
848
+0%
|
873
+3%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
68
|
68
|
68
|
68
|
68
|
68
|
|